You are here

  • Home
  • Archive
  • Volume 11, Issue 1
  • Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: January 2023 to March 2026

AbstractFullPdf
Jan 202340741594
Feb 202327327395
Mar 202320721176
Apr 202319619752
May 202314114258
Jun 202317317748
Jul 202312512551
Aug 202317517731
Sep 202312612643
Oct 2023959866
Nov 202310811250
Dec 202310610857
Jan 202410310673
Feb 2024717138
Mar 2024717170
Apr 202415815886
May 202410210548
Jun 2024888951
Jul 2024939451
Aug 2024545745
Sep 2024808053
Oct 2024777757
Nov 2024757652
Dec 2024767744
Jan 202510310351
Feb 202513513538
Mar 2025686851
Apr 202513914067
May 2025889051
Jun 2025616228
Jul 2025110
Aug 2025110
Sep 2025110
Oct 2025111
Mar 2026110
Total377938251676